RANDOMISED CONTROLLED CLINICAL TRIAL OF NARAYAN TAILA UTTARBASTI IN VATASHTHILA WITH SPECIAL REFERENCE TO BENIGN PROSTATIC HYPERPLASIA

Abstract

Benign prostatic hyperplasia is a common disease with well defined age incidence. The present modern established conservative management includes use of α blockers and 5α reductase inhibitors. But both of drugs cause various side effects. As it is a senile disease, people may not be fit for TURP or prostatectomy. In Ayurved Samhitas, symptoms of Benign Prostatic Hyperplasia are described under Mootraghata. There are 12 types of mootraghata; one of them is Vatashthila.Various ayurvedic drugs were studied previously as a conservative measure & are found effective also. But since the incidence of this disease is very much, we can study the effects of various other drugs or therapies also as conservative management. Though uttarbasti is a traditionally used therapy, it’s efficacy is not yet evaluated with Narayan Taila in benign prostatic hyperplasia. Uttarbasti is a non invasive procedure. Moreover the cost of this treatment modality is very much less as compared to other conservative or surgical managements. Use of Uttarbasti may avoid surgery which ultimately results in increased quality of life of patients. So, in the present clinical study, efficacy of Narayan taila Uttarbasti in Vatashthila with special reference to Benign Prostatic Hyperplasia is evaluated. At the end of study, it is found that Narayan taila Uttarbasti is found effective in BPH than that of C.Tamsulosin HCl with respect to frequency, urgency, nocturia & force of urine stream. Also Narayan taila Uttarbasti is found effective in reducing the post void residual urine volume. Thus, at the end of study, it is concluded that there is much more increase in the quality of life of patients due to this non invasive treatment modality.